Jonathan Moses MD
@mosespedsibd.bsky.social
Endowed Medical Director for Pediatric IBD at Stanford Medicine Children’s Health. Guitarist/bassist for hire.
Reposted by Jonathan Moses MD
In today's episode, hosts @pllumd.bsky.social & @jasonsilverman.bsky.social talk to Dr. Rima Fawaz from Yale about #GLP1 for children w MASLD! 💉
➡️ What is the current evidence?
➡️ Benefits and adverse effects
➡️ Where should we be positioning GLP-1s?
Listen now! 🎧
www.buzzsprout.com/581062/episo...
➡️ What is the current evidence?
➡️ Benefits and adverse effects
➡️ Where should we be positioning GLP-1s?
Listen now! 🎧
www.buzzsprout.com/581062/episo...
February 24, 2025 at 1:00 PM
In today's episode, hosts @pllumd.bsky.social & @jasonsilverman.bsky.social talk to Dr. Rima Fawaz from Yale about #GLP1 for children w MASLD! 💉
➡️ What is the current evidence?
➡️ Benefits and adverse effects
➡️ Where should we be positioning GLP-1s?
Listen now! 🎧
www.buzzsprout.com/581062/episo...
➡️ What is the current evidence?
➡️ Benefits and adverse effects
➡️ Where should we be positioning GLP-1s?
Listen now! 🎧
www.buzzsprout.com/581062/episo...
Reposted by Jonathan Moses MD
NEW Year-in-Review in #NatureReviewsGastroHep highlighting the key papers in #IBD in 2024
Biologic agents for IBD come of age as host–microbe interactions emerge
By Leolin Katsidzira & Benjamin Misselwitz
www.nature.com/articles/s41...
#IBDsky #GastroSky #Microsky 🧪
Biologic agents for IBD come of age as host–microbe interactions emerge
By Leolin Katsidzira & Benjamin Misselwitz
www.nature.com/articles/s41...
#IBDsky #GastroSky #Microsky 🧪
Biologic agents for IBD come of age as host–microbe interactions emerge - Nature Reviews Gastroenterology & Hepatology
In 2024, there were major advances in inflammatory bowel disease research. Treatment strategies with biologic agents for inflammatory bowel disease matured, and gut microbiota–bacteriophage–host inter...
www.nature.com
December 16, 2024 at 2:32 PM
NEW Year-in-Review in #NatureReviewsGastroHep highlighting the key papers in #IBD in 2024
Biologic agents for IBD come of age as host–microbe interactions emerge
By Leolin Katsidzira & Benjamin Misselwitz
www.nature.com/articles/s41...
#IBDsky #GastroSky #Microsky 🧪
Biologic agents for IBD come of age as host–microbe interactions emerge
By Leolin Katsidzira & Benjamin Misselwitz
www.nature.com/articles/s41...
#IBDsky #GastroSky #Microsky 🧪
Reposted by Jonathan Moses MD
Join us at Crohn’s & Colitis Congress® 2025
YouTube video by Crohn's & Colitis Foundation
www.youtube.com
December 20, 2024 at 3:39 PM
Reposted by Jonathan Moses MD
Early Anti-TNF (infliximab, adalimumab) therapy prevents perianal fistulas in children with Crohn’s disease.
TNF Inhibitors Prevent Complications in Kids with Crohn’s Disease, Recommended as First-Line Therapies - Global Health News Wire
Study confirms that the use of anti-tumor necrosis factor drugs dramatically reduces the likelihood of perianal fistulas Early treatment of pediatric Crohn’s disease with anti-tumor necrosis factor me...
globalhealthnewswire.com
December 24, 2024 at 5:24 PM
Early Anti-TNF (infliximab, adalimumab) therapy prevents perianal fistulas in children with Crohn’s disease.